1. Goodwin, FK, Jamison, KR. Manic-depressive illness: bipolar disorders and recurrent depression. Oxford: Oxford University Press, 2007.
Google Scholar2. World Health Organization . International statistical classification of diseases and related health problems (10th revision). 2nd ed. 2010, https://icd.who.int/browse10/
Google Scholar3. American Psychiatric Association . Diagnostic and statistical manual of mental disorders fourth edition (DSM-IV). 4th ed. Washington, DC: American Psychiatric Association, 2000.
Google Scholar4. American Psychiatric Association . Diagnostic and statistical manual of mental disorders fifth edition (DSM-5). 5th ed. Washington, DC: American Psychiatric Association, 2013.
Google Scholar | Crossref5. Phillips, M. Dysthymia and cyclothymia in ICD-11. World Psychiatry 2012; 11: 53–58.
Google Scholar6. Reed, GM, First, MB, Kogan, CS, et al. Innovations and changes in the ICD-11 classification of mental, behavioural and neurodevelopmental disorders. World Psychiatry 2019; 18: 3–19. DOI: 10.1002/wps.20611.
Google Scholar | Crossref | Medline7. Merikangas, KR, Akiskal, HS, Angst, J, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the national comorbidity survey replication. Arch Gen Psychiatry 2007; 64: 543–552. DOI: 10.1001/archpsyc.64.5.543.
Google Scholar | Crossref | Medline8. Merikangas, KR, Jin, R, He, J-P, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 2011; 68: 241–251. DOI: 10.1001/archgenpsychiatry.2011.12.
Google Scholar | Crossref | Medline9. Bauer, M, Pfennig, A. Epidemiology of bipolar disorders. Epilepsia 2005; 46(Suppl. 4): 8–13. DOI: 10.1111/j.1528-1167.2005.463003.x.
Google Scholar | Crossref | Medline10. López-Muñoz, F, Shen, WW, D’Ocon, P, et al. A history of the pharmacological treatment of bipolar disorder. Int J Mol Sci 2018; 19: 2143. DOI: 10.3390/ijms19072143.
Google Scholar | Crossref11. Weisler, RH, Calabrese, JR, Bowden, CL, et al. Discovery and development of lamotrigine for bipolar disorder: a story of serendipity, clinical observations, risk taking, and persistence. J Affect Disord 2008; 108: 1–9. DOI: 10.1016/j.jad.2007.09.012.
Google Scholar | Crossref | Medline12. Smith, D, Baker, G, Davies, G, et al. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia 1993; 34: 312–322. DOI: 10.1111/j.1528-1157.1993.tb02417.x.
Google Scholar | Crossref | Medline | ISI13. GlaxoSmithKline . Annual report 2003. https//www.gsk.com/media/2669/annual-report-2003.pdf (accessed 12 September 2021).
Google Scholar14. Geddes, JR, Gardiner, A, Rendell, J, et al. Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2 × 2 factorial randomised trial. Lancet Psychiat 2016; 3: 31–39. DOI: 10.1016/S2215-0366(15)00450-2.
Google Scholar | Crossref | Medline | ISI15. Stahl, SM, Morrissette, DA, Faedda, G, et al. Guidelines for the recognition and management of mixed depression. CNS Spectr 2017; 22: 203–219. DOI: 10.1017/S1092852917000165.
Google Scholar | Crossref | Medline16. Harrison, PJ, Cipriani, A, Harmer, CJ, et al. Innovative approaches to bipolar disorder and its treatment. Ann N Y Acad Sci 2016; 1366: 76–89. DOI: 10.1111/nyas.13048.
Google Scholar | Crossref | Medline | ISI17. Ketter, TA, Manji, HK, Post, RM. Potential mechanisms of action of lamotrigine in the treatment of bipolar disorders. J Clin Psychopharmacol 2003; 23: 484–495.
Google Scholar | Crossref | Medline18. Hahn, C-G, Gyulai, L, Baldassano, CF, et al. The current understanding of lamotrigine as a mood stabilizer. J Clin Psychiatry 2004; 65: 791–804.
Google Scholar | Crossref | Medline19. Ng, F, Hallam, K, Lucas, N, et al. The role of lamotrigine in the management of bipolar disorder. Neuropsychiatr Dis Treat 2007; 3: 463–474.
Google Scholar | Medline20. Calabrese, JR, Bowden, CL, Sachs, GS, et al. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. J Clin Psychiatry 1999; 60: 79–88.
Google Scholar | Crossref | Medline | ISI21. Calabrese, JR, Suppes, T, Bowden, CL, et al. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. J Clin Psychiatry 2000; 61: 841–850. DOI: 10.4088/jcp.v61n1106.
Google Scholar | Crossref | Medline | ISI22. Normann, C, Hummel, B, Scharer, LO, et al. Lamotrigine as adjunct to paroxetine in acute depression: a placebo-controlled, double-blind study. J Clin Psychiatry 2002; 63: 337–344. DOI: 10.4088/jcp.v63n0411.
Google Scholar | Crossref | Medline | ISI23. Obrocea, GV, Dunn, RM, Frye, MA, et al. Clinical predictors of response to lamotrigine and gabapentin monotherapy in refractory affective disorders. Biol Psychiat 2002; 51: 253–260. DOI: 10.1016/S0006-3223(01)01206-9.
Google Scholar | Crossref | Medline24. Barbosa, L, Berk, M, Vorster, M. A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes. J Clin Psychiatry 2003; 64: 403–407.
Google Scholar | Crossref | Medline | ISI25. Bowden, CL, Calabrese, JR, Sachs, G, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003; 60: 392–400. DOI: 10.1001/archpsyc.60.4.392.
Google Scholar | Crossref | Medline26. Calabrese, JR, Bowden, CL, Sachs, G, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 2003; 64: 1013–1024. DOI: 10.4088/jcp.v64n0906.
Google Scholar | Crossref | Medline | ISI27. van der Loos, ML, Mulder, PG, Hartong, EG, et al. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial. J Clin Psychiatry 2009; 70: 223–231.
Google Scholar | Crossref | Medline | ISI28. Wang, Z, Gao, K, Kemp, DE, et al. Lamotrigine adjunctive therapy to lithium and divalproex in depressed patients with rapid cycling bipolar disorder and a recent substance use disorder: a 12-week, double-blind, placebo-controlled pilot study. Psychopharmacol Bull 2010; 43: 5–21.
Google Scholar | Medline29. van der Loos, ML, Mulder, P, Hartong, EG, et al. Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel design. Bipolar Disord 2011; 13: 111–117. DOI: 10.1111/j.1399-5618.2011.00887.x.
Google Scholar | Crossref | Medline | ISI30. Kemp, DE, Gao, K, Fein, EB, et al. Lamotrigine as add-on treatment to lithium and divalproex: lessons learned from a double-blind, placebo-controlled trial in rapid-cycling bipolar disorder. Bipolar Disord 2012; 14: 780–789. DOI: 10.1111/bdi.12013.
Google Scholar | Crossref | Medline | ISI31. Findling, RL, Chang, K, Robb, A, et al. Adjunctive maintenance lamotrigine for pediatric bipolar I disorder: a placebo-controlled, randomized withdrawal study. J Am Acad Child Adolesc Psychiatry 2015; 54: 1020–1031. DOI: 10.1016/j.jaac.2015.09.017.
Google Scholar | Crossref | Medline32. Brown, EB, McElroy, SL, Keck, PE, et al. A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression. J Clin Psychiatry 2006; 67: 1025–1033.
Google Scholar | Crossref | Medline | ISI33. Brown, E, Dunner, DL, McElroy, SL, et al. Olanzapine/fluoxetine combination vs. Lamotrigine in the 6-month treatment of bipolar I depression. Int J Neuropsychopharmacol 2009; 12: 773–782. DOI: 10.1017/S1461145708009735.
Google Scholar | Crossref | Medline34. Suppes, T, Marangell, LB, Bernstein, IH, et al. A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depression. J Affect Disord 2008; 111: 334–343. DOI: 10.1016/j.jad.2008.02.004.
Google Scholar | Crossref | Medline | ISI35. Schaffer, A, Zuker, P, Levitt, A. Randomized, double-blind pilot trial comparing lamotrigine versus citalopram for the treatment of bipolar depression. J Affect Disord 2006; 96: 95–99. DOI: 10.1016/j.jad.2006.05.023.
Google Scholar | Crossref | Medline | ISI36. Ichim, L, Berk, M, Brook, S. Lamotrigine compared with lithium in mania: a double-blind randomized controlled trial. Ann Clin Psychiatry 2000; 12: 5–10. DOI: 10.3109/10401230009147081.
Google Scholar | Crossref | Medline37. Licht, RW, Nielsen, JN, Gram, LF, et al. Lamotrigine versus lithium as maintenance treatment in bipolar I disorder: an open, randomized effectiveness study mimicking clinical practice. The 6th trial of the Danish University Antidepressant Group (DUAG-6). Bipolar Disord 2010; 12: 483–493. DOI: 10.1111/j.1399-5618.2010.00836.x.
Google Scholar | Crossref | Medline | ISI38. Pavuluri, MN, Henry, DB, Moss, M, et al. Effectiveness of lamotrigine in maintaining symptom control in pediatric bipolar disorder. J Child Adolesc Psychopharmacol 2009; 19: 75–82. DOI: 10.1089/cap.2008.0107.
Google Scholar | Crossref | Medline39. Pan, PY, Lee, MS, Lo, MC, et al. Olanzapine is superior to lamotrigine in the prevention of bipolar depression: a naturalistic observational study. BMC Psychiatry 2014; 14: 145. DOI: 10.1186/1471-244x-14-145.
Google Scholar | Crossref | Medline40. Terao, T, Ishida, A, Kimura, T, et al. Assessment of safety and efficacy of lamotrigine over the course of 1-year observation in Japanese patients with bipolar disorder: post-marketing surveillance study report. Neuropsychiatr Dis Treat 2017; 13: 1441–1448.
Google Scholar | Crossref | Medline41. Goldberg, JF, Calabrese, JR, Saville, BR, et al. Mood stabilization and destabilization during acute and continuation phase treatment for bipolar I disorder with lamotrigine or placebo. J Clin Psychiatry 2009; 70: 1273–1280. DOI: 10.4088/JCP.08m04381.
Google Scholar | Crossref | Medline | ISI42. Goodwin, GM, Bowden, CL, Calabrese, JR, et al. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry 2004; 65: 432–441.
Google Scholar | Crossref | Medline | ISI43. Calabrese, JR, Goldberg, JF, Ketter, TA, et al. Recurrence in bipolar I disorder: a post hoc analysis excluding relapses in two double-blind maintenance studies. Biol Psychiat 2006; 59: 1061–1064. DOI: 10.1016/j.biopsych.2006.02.034.
Google Scholar | Crossref | Medline44. Vieta, E, Günther, O, Locklear, J, et al. Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials. Int J Neuropsychopharmacol 2011; 14: 1029–1049. DOI: 10.1017/s1461145711000885.
Google Scholar | Crossref | Medline45. Oya, K, Sakuma, K, Esumi, S, et al. Efficacy and safety of lithium and lamotrigine f